Mast Therapeutics Company Profile (NYSE:MSTX)

About Mast Therapeutics

Mast Therapeutics logoMast Therapeutics, Inc. is a biopharmaceutical company. The Company develops clinical-stage therapies for serious or life-threatening diseases with unmet needs. The Company focuses on developing new therapies for sickle cell disease, a chronic and genetic disorder classified as a rare, or orphan, disease in the United States of America and European Union, and for heart failure, a condition with an unmet need for treatment options. The Company's segment is engaged in the business of developing therapies for serious or life-threatening diseases. The Company focuses on its Molecular Adhesion and Sealant Technology (MAST) platform, to develop MST-188 (vepoloxamer) Injection, its lead product candidate. The Company also develops AIR001, a sodium nitrite solution for intermittent inhalation through nebulizer. The Company's AIR001 is in Phase II clinical development for the treatment of patients with HFpEF.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: MSTX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.13
  • 50 Day Moving Average: $0.133
  • 200 Day Moving Average: $0.190
  • 52-Week Range: $0.07 - $0.71
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.04
  • P/E Growth: 0.000
  • Market Cap: $29.78M
  • Outstanding Shares: 238,230,000
Additional Links:
Companies Related to Mast Therapeutics:

Analyst Ratings

Consensus Ratings for Mast Therapeutics (NYSE:MSTX) (?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $2.52 (1,918.00% upside)

Analysts' Ratings History for Mast Therapeutics (NYSE:MSTX)
Show:
DateFirmActionRatingPrice TargetDetails
10/14/2016S&P Equity ResearchBoost Price Target$0.08 -> $0.09View Rating Details
9/23/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
9/21/2016LaidlawDowngradeBuy -> NeutralView Rating Details
9/21/2016Maxim GroupDowngradeBuy -> HoldView Rating Details
8/1/2016Roth CapitalReiterated RatingBuy$2.00View Rating Details
7/28/2016Canaccord GenuityReiterated RatingBuy$3.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Mast Therapeutics (NYSE:MSTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016Q316($0.05)($0.04)ViewListenView Earnings Details
8/9/2016Q2($0.06)($0.05)ViewN/AView Earnings Details
5/6/2016Q116($0.06)($0.06)ViewN/AView Earnings Details
3/14/2016Q415($0.06)($0.06)ViewN/AView Earnings Details
11/12/2015Q315($0.06)($0.06)ViewListenView Earnings Details
8/12/2015($0.04)($0.06)ViewN/AView Earnings Details
8/12/2015Q215($0.04)($0.06)ViewListenView Earnings Details
5/11/2015Q1($0.06)($0.06)ViewN/AView Earnings Details
3/24/2015Q414($0.06)($0.05)ViewN/AView Earnings Details
10/31/2014Q314($0.06)($0.06)ViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)ViewN/AView Earnings Details
5/5/2014Q114($0.07)($0.06)ViewN/AView Earnings Details
3/26/2014($0.07)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mast Therapeutics (NYSE:MSTX)
Current Year EPS Consensus Estimate: $-0.200 EPS
Next Year EPS Consensus Estimate: $-0.120 EPS

Dividends

Dividend History for Mast Therapeutics (NYSE:MSTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mast Therapeutics (NYSE:MSTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/27/2015Brandi RobertsCFOBuy38,000$0.50$19,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mast Therapeutics (NYSE:MSTX)
DateHeadline
News IconCritical Chart Information For Mast Therapeutics, Inc. (MSTX) - NY Stock News (NYSE:MSTX)
nystocknews.com - February 22 at 6:49 PM
News IconInvestor Corner: Checking the Numbers on Mast Therapeutics, Inc. (AMEX:MSTX) - Midway Monitor (NYSE:MSTX)
midwaymonitor.com - February 22 at 8:35 AM
News IconThe Charts For Mast Therapeutics, Inc. (MSTX) Is Attracting Massive Attention - NY Stock News (NYSE:MSTX)
nystocknews.com - February 22 at 8:35 AM
biz.yahoo.com logoMAST THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NYSE:MSTX)
biz.yahoo.com - February 22 at 8:34 AM
News IconA Keen Look At The Chart For Mast Therapeutics, Inc. (MSTX) - NY Stock News (NYSE:MSTX)
nystocknews.com - February 21 at 6:14 PM
News IconMast Therapeutics, Inc. (:MSTX) Seeing Rampant Activity Today - Winfield Review (NYSE:MSTX)
winfieldreview.com - February 21 at 6:14 PM
News IconThe Case for and Against Mast Therapeutics, Inc. (MSTX) - StockNewsJournal (NYSE:MSTX)
stocknewsjournal.com - February 21 at 6:14 PM
News IconAnalyst Hints Surrounding Mast Therapeutics, Inc. (MSTX) | Post ... - Post Analyst (NYSE:MSTX)
postanalyst.com - February 20 at 10:00 AM
istreetwire.com logoEye Catching Stocks: Cobalt International Energy, Inc. (CIE), Mast Therapeutics, Inc. (MSTX), Pandora Media, Inc. (P) - iStreetWire (NYSE:MSTX)
istreetwire.com - February 17 at 4:29 PM
News IconHot Stocks Report: Syntel, Inc. (SYNT), Mast Therapeutics, Inc. (MSTX) - Post Analyst (NYSE:MSTX)
postanalyst.com - February 17 at 4:29 PM
News IconA Look Ahead For 2 Stocks: Mast Therapeutics, Inc. (MSTX), Cobalt International Energy, Inc. (CIE) - Post Analyst (NYSE:MSTX)
postanalyst.com - February 14 at 8:45 PM
News IconHeatwave to maintain energy demand in SA (NYSE:MSTX)
mundoaguaysaneamiento.net - February 9 at 7:42 PM
News IconMen earn £12500 less in 20s than generation before, research shows (NYSE:MSTX)
mundoaguaysaneamiento.net - February 9 at 7:42 PM
News IconTrading Radar: Zooming in on Shares of Mast Therapeutics Inc. (MSTX) - Piedmont Register (NYSE:MSTX)
piedmontregister.com - February 9 at 1:26 AM
istreetwire.com logoInvestor's Watch List: Gigamon Inc. (GIMO), Callon Petroleum ... - iStreetWire (NYSE:MSTX)
istreetwire.com - February 6 at 6:45 PM
News Icon5 Year Earning Growth of Mast Therapeutics, Inc. (AMEX:MSTX) is reported at 0 - The Newburgh Press (NYSE:MSTX)
newburghpress.com - February 3 at 7:26 PM
News IconLawmakers weigh override of Gov. Baker's veto of pay raises (NYSE:MSTX)
mundoaguaysaneamiento.net - February 2 at 7:33 PM
News IconEarnings Forecast Research on Mast Therapeutics, Inc. (MSTX) (NYSE:MSTX)
xboxonezone.com - February 2 at 7:33 PM
News IconBoom or Bust? Is there any value in Mast Therapeutics, Inc. (:MSTX) - Prospect Journal (NYSE:MSTX)
prospectjournal.com - February 1 at 6:29 AM
News IconWatching Technical Levels on Shares of Mast Therapeutics Inc. (MSTX) - Sherwood Daily (NYSE:MSTX)
sherwooddaily.com - January 30 at 7:22 PM
News IconCheap Stock Alert on Mast Therapeutics, Inc. (:MSTX) - Prospect Journal (NYSE:MSTX)
prospectjournal.com - January 30 at 7:22 PM
News IconMast Therapeutics, Inc. (MSTX): What's the Story? - StockNewsJournal (NYSE:MSTX)
stocknewsjournal.com - January 30 at 7:22 PM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Mast Therapeutics, Inc. (:MSTX) - Nelson Research (NYSE:MSTX)
nelsonobserver.com - January 28 at 11:47 PM
News IconLooking at the Tea Leaves for Mast Therapeutics, Inc. (MSTX) - The USA Commerce (NYSE:MSTX)
theusacommerce.com - January 28 at 1:54 AM
News IconRange Watch on Technical Indicators for Mast Therapeutics Inc. (MSTX) - Sherwood Daily (NYSE:MSTX)
sherwooddaily.com - January 26 at 10:18 PM
News IconJust the Facts on Mast Therapeutics, Inc. (MSTX) - StockNewsJournal (NYSE:MSTX)
stocknewsjournal.com - January 26 at 10:18 PM
News IconInvestors are Looking at Levels for Mast Therapeutics Inc. (MSTX) - Sherwood Daily (NYSE:MSTX)
sherwooddaily.com - January 26 at 1:13 AM
istreetwire.com logoEquities Trend Analysis: Emerson Electric Co. (EMR), Mast Therapeutics, Inc. (MSTX), The Blackstone Group L.P. (BX) - iStreetWire (NYSE:MSTX)
istreetwire.com - January 26 at 1:13 AM
4-traders.com logoMast Therapeutics, Inc. (NYSEMKT:MSTX) Files An 8-K Entry into a Material Definitive Agreement (NYSE:MSTX)
www.4-traders.com - January 25 at 8:12 PM
smarteranalyst.com logoA Glimpse into the Mast Therapeutics Inc (MSTX) and Savara Merger (NYSE:MSTX)
www.smarteranalyst.com - January 23 at 6:59 PM
biz.yahoo.com logoMAST THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princi (NYSE:MSTX)
biz.yahoo.com - January 23 at 6:59 PM
News IconMA Watch on Shares of Mast Therapeutics Inc. (MSTX) - Sherwood Daily (NYSE:MSTX)
sherwooddaily.com - January 23 at 10:00 AM
News IconMast Therapeutics, Inc. (NYSEMKT:MSTX) Stock Price Decreases ... - Highland Mirror (NYSE:MSTX)
www.highlandmirror.com - January 23 at 10:00 AM
News IconMast Therapeutics, Inc. (NYSEMKT:MSTX) Eps and Price target Analysis (NYSE:MSTX)
flapship.com - January 21 at 6:28 PM
istreetwire.com logoStocks In Queue: Abbott Laboratories (ABT), U.S. Bancorp (USB ... - iStreetWire (NYSE:MSTX)
istreetwire.com - January 20 at 7:27 PM
News IconMast Therapeutics, Inc. (AMEX:MSTX) 52 Week High stands at 0.71 - The Newburgh Press (NYSE:MSTX)
newburghpress.com - January 20 at 2:27 AM
News IconLas Vegas Sands Corp. (NYSE:LVS):Brokerage Firm Rating Analysis (NYSE:MSTX)
baddgoddess.com - January 19 at 9:26 PM
News IconTrend Strength Monitor on Shares of Mast Therapeutics Inc. (MSTX) - Sherwood Daily (NYSE:MSTX)
sherwooddaily.com - January 18 at 7:15 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: Mast Therapeutics, Inc. (:MSTX) - Wall Street Beacon (NYSE:MSTX)
wsbeacon.com - January 14 at 11:47 PM
News IconTraders Alert: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Mobile TeleSystems PJSC (NYSE:MBT) - The Newburgh Press (NYSE:MSTX)
newburghpress.com - January 14 at 1:02 AM
News IconAre Institutions Jumping Ship on Mast Therapeutics, Inc. (:MSTX) - Wall Street Beacon (NYSE:MSTX)
wsbeacon.com - January 12 at 12:17 AM
News IconCalling all Bargain Hunters: Stock Update on Mast Therapeutics, Inc. (:MSTX) - Prospect Journal (NYSE:MSTX)
prospectjournal.com - January 11 at 5:35 AM
bizjournals.com logoAnother public company is on Austin's horizon, this time a drugmaker heading for NYSE (NYSE:MSTX)
www.bizjournals.com - January 10 at 7:32 PM
News IconRestless Stock Touches Most Active List For Monday: Mast Therapeutics, Inc. (:MSTX) (NYSE:MSTX)
viveremilano.biz - January 10 at 7:32 PM
News IconMast Therapeutics, Inc. (NYSEMKT:MSTX) Closed the Last Trading Session at $0.15 (NYSE:MSTX)
diariocatolico.net - January 10 at 7:32 PM
News IconMast Therapeutics, Inc. (NYSEMKT:MSTX) Closed the Last Trading Session at $0.15 - The Newburgh Press (NYSE:MSTX)
newburghpress.com - January 10 at 7:32 PM
wsj.com logo[$$] Savara to Merge With Mast Therapeutics (NYSE:MSTX)
www.wsj.com - January 10 at 7:32 PM
wallstrt24.com logo2 Notable Runners Mast Therapeutics Inc (NYSEMKT:MSTX), Corning Incorporated (NYSE:GLW) - Wall Street 24 (NYSE:MSTX)
wallstrt24.com - January 10 at 8:30 AM
istreetwire.com logoStocks To Track: NiSource Inc. (NI), Mast Therapeutics, Inc. (MSTX), Archer-Daniels-Midland Company (ADM) - iStreetWire (NYSE:MSTX)
istreetwire.com - January 9 at 7:23 PM
News IconAre There Catalysts to Propel This Stock Forward: Mast Therapeutics, Inc. (:MSTX) - Prospect Journal (NYSE:MSTX)
prospectjournal.com - January 9 at 7:23 PM

Social

What is Mast Therapeutics' stock symbol?

Mast Therapeutics trades on the New York Stock Exchange (NYSE) under the ticker symbol "MSTX."

Where is Mast Therapeutics' stock going? Where will Mast Therapeutics' stock price be in 2017?

5 brokerages have issued twelve-month price targets for Mast Therapeutics' stock. Their predictions range from $0.09 to $5.00. On average, they expect Mast Therapeutics' share price to reach $2.52 in the next twelve months.

How do I buy Mast Therapeutics stock?

Shares of Mast Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Mast Therapeutics stock cost?

One share of Mast Therapeutics stock can currently be purchased for approximately $0.13.

Mast Therapeutics (NYSE:MSTX) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Mast Therapeutics (NYSE:MSTX)

Earnings History Chart

Earnings by Quarter for Mast Therapeutics (NYSE:MSTX)

Dividend History Chart

Dividend Payments by Quarter for Mast Therapeutics (NYSE:MSTX)

Last Updated on 2/22/2017 by MarketBeat.com Staff